ArticleFrontiers in neurology2024

Case report: Transition from anti-CD20 therapy to inebilizumab for 14 cases of neuromyelitis optica spectrum disorder.

Benjamin Osborne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.